Skip to content

P-syn Deposits in Autonomic Skin Fiber Subtypes May Help Distinguish MSA and PD+OH

P-syn Deposits in Autonomic Skin Fiber Subtypes May Help Distinguish MSA and PD+OH

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053686
Enrollment
Unknown
Registered
2021-11-27
Start date
2022-02-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple system atrophy, Parkinson's disease

Interventions

MSA group:nothing
PD+OH group:nothing

Sponsors

Zhongda Hospital affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. MSA group: Aged 45-70 years; MMSE >= 27 points; patients diagnosed as likely to have MSA according to the Gilman diagnostic criteria revised in 2008; 2. PD+OH group: Aged 45-70 years; MMSE >= 27 points; PD was diagnosed according to the latest diagnostic criteria for Parkinson's disease (2015) of the International Movement Disorders Society (MDS), and patients were diagnosed with PD according to the American Academy of Autonomic Neuroscience (AAS)) and the American Academy of Neurology (AAN) 1996 diagnostic criteria for orthostatic hypotension in patients diagnosed with orthostatic hypotension (OH).

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity to lidocaine anesthetics; 2. Those with bleeding tendency or scar constitution; 3. Those with skin diseases; 4. Those who refuse to sign informed consent for skin biopsy; 5. There is a positive family history of autonomic disorder; 6. Susceptible factors for autonomic neuropathy: diabetes, autoimmune diseases, paraneoplastic diseases, infectious diseases, thyroid diseases and vitamin B12, vitamin B6 deficiency, etc.; 7. Suffering from other known serious medical diseases, including severe liver and kidney failure, cardiac insufficiency, advanced cancer, etc.

Design outcomes

Primary

MeasureTime frame
The amount of p-syn deposits in the skin noradrenergic or cholinergic fibers;

Secondary

MeasureTime frame
Head-up tilt testing;clinical scales;Urodynamic inspections;post-void residual bladder volume using ultrasound;lying and standing blood pressure;24-hour ambulatory blood pressure measurement;24-Holter electrocardiogram;Sympathetic skin response electrophysiological tests;

Countries

China

Contacts

Public ContactWu Di

Zhongda Hospital affiliated to Southeast University

doctor.diwu@gmail.com+86 18502565457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026